欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/0745/001
药品名称FULVESTRANT 250mg/5ml Solution for injection in pre-filled syringe
活性成分
    • fulvestrant 250.0 mg/5ml
剂型Solution for injection in prefilled syringe
上市许可持有人Actavis Group PTC ehf. Reykjavíkurvegi 76-78 Hafnarfjördur 220 Iceland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Lithuania (LT)
    • Austria (AT)
    • Belgium (BE)
    • Bulgaria (BG)
      Fulvestrant Accord 250 mg Solution for injection in pre-filled syringe
    • Croatia (HR)
      Fulvestrant Accord 250 mg otopina za injekciju u napunjenoj štrcaljki
    • Cyprus (CY)
      Fulvestrant 250mg Solution fo rinjection in prefilled syringe
    • Czechia (CZ)
      Fulvestrant 250 mg injekční roztok v předplněné injekční stříkačce
    • Denmark (DK)
    • Estonia (EE)
      FULVESTRANT ACCORD
    • Iceland (IS)
      Fulvestrant Accord 250 mg stungulyf, lausn í áfylltri sprautu
    • Italy (IT)
    • Netherlands (NL)
      Fulvestrant 250 mg oplossing voor injectie in voorgevulde spuit
    • Norway (NO)
    • Poland (PL)
      Fulwestrant Accord
    • Portugal (PT)
    • Romania (RO)
    • Slovenia (SI)
    • Sweden (SE)
    • France (FR)
    • Finland (FI)
    • Germany (DE)
      Fulvestrant 250 mg Injektionslösung in einer Fertigspritze
    • Greece (GR)
    • Hungary (HU)
      FULVESZTRANT ACCORD 250 mg oldatos injekció előretöltött fecskendő
    • Slovakia (SK)
    • Spain (ES)
    • United Kingdom (Northern Ireland) (XI)
许可日期2017/09/29
最近更新日期2024/04/24
药物ATC编码
    • L02BA03 fulvestrant
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase